Skip to main content

$6,371.6 Million dPCR and qPCR Market will reach 9.1% of CAGR by 2025 with Strategic Insights by Top Players - Bio-Rad Laboratories, QIAGEN, TaKARA BIO, Agilent Technologies, bioMérieux, Danaher, Fluidigm Corporation

Press release   •   Jun 28, 2019 11:32 IST

dPCR and qPCR Market

The Insight Partners adds "dPCR and qPCR Market to 2025" to its database. This report is a comprehensive evaluation of the market trends of industry. The report covers a detailed competitive outlook that includes the market share and company profiles of key players operating in the global market.

dPCR and qPCR are PCR technologies which have evolved over the years from thermostable polymerases, development of automated thermocyclers to latest digital PCR (d-PCR) methodologies. dPCR and qPCR have been extensively used in molecular diagnostics and therefore have enabled detection of various diseases. The report would be of an interest to various stakeholders operating in the dPCR and qPCR market. These stakeholders include hospitals, research institutes, medical device suppliers, diagnostic centers, academic institutes, market research, equipment manufacturers, and consulting firms.

The global dPCR and qPCR market is expected to reach US$ 6,371.6 Mn in 2025 from US$ 3,255.5 Mn in 2017. The market is estimated to grow with a CAGR of 9.1% from 2018-2025.

Get Sample Copy at

According to the Genetic Home References, about 1 in 200,000 people in the United States are born with syndrome each year. An estimated 15,000 infants with syndrome B were born last year worldwide. Moreover, approximately 1 percent of people in the United States develop disorder D during their lifetimes. The lifetime risk of developing disorder D is 1 in 100. The adoption of digital PCR is improving as the pathologists are trying to track the use of this technology to target various specific DNA sequences as well as to diagnose and design various clinical tests. Digital PCR can target specific DNA sequences in just one molecule of DNA. This new tool allows researchers to isolate rare genetic mutations too difficult to segregate with real-time PCR. Thus, the increasing incidence of genetic diseases in which dPCR and qPCR techniques can be used for diagnosis and treatment options are expected to support the growth of the market over the forecast years.

Increasing incidence of genetic diseases is expected to drive the growth of the market. However, high cost of PCR systems is expected to hamper the growth of the market. Genes are considered to be the building blocks of heredity. The genes are passed from a parent to a child, as well as they hold the DNA that is usually considered to instruct and guide protein synthesis. Mutation, on the other hand refers to a sudden change in a single or multiple genes. The mutation can result in dysfunction of the gene resulting in a medical condition called genetic disorder. According to the National organizations information on genetic conditions or birth defects, though individual genetic disorders are rare, collectively they comprise over 15,500 recognized genetic disorders. Moreover, according to the Genetic Disorders UK, it is estimated that one in 25 children is affected by a genetic disorder and therefore 30,000 babies and children are newly diagnosed in the UK each year.

While digital and real-time PCR is a very robust technique and has significant advantages in various research applications, the cost of PCR machines as well as the cost and skills required to run the sets is the biggest drawbacks of the technique. According to the SafePath Laboratories, LLC, an entry level PCR machine begins at around US$ 10,000, whereas the manual digital PCR costs between US$65,000 to USD$70,000 and can go up to $100,000 for the automated digital ones. In case of real time PCR, the machine cost ranges between US$ 20,000 and US$30,000.

This can be disadvantageous when competing various other technologies. Although digital PCR and real-time PCR is witnessing exponential growth, the cost factor can negatively impact the adoption and growth of the global market in the near future. In addition to the high costs of the machines, the cost of consumables, reagents and accessories required for performing PCR tests are also on the expensive side. Thus, the unaffordability of the systems as well as consumables and reagents are expected to refrain the dPCR and qPCR market to grow in the global industry.

Check Discount at

The objective of the study is to describe, define, and forecast the dPCR and qPCR market by technology, product & services, application, end user and region. The report also provide detailed information regarding the major factors influencing growth of the market (drivers, restraints, opportunities, and trends). The report helps to analyze market with respect to individual growth trends, prospects, and contributions to the overall market.

The report analyzes factors affecting dPCR and qPCR market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions. The report also includes the profiles of key dPCR and qPCR manufacturing companies along with their SWOT analysis and market strategies.

Global dPCR and qPCR Market - By Technology
Digital PCR (dPCR)
Quantitative PCR (qPCR)

Global DPCR and qPCR Market - By Product
Reagents & Consumables
Software and Services

Global DPCR and qPCR Market - By Application
Clinical Application
Pathogen Testing
Oncology Testing
Blood Screening Testing
Research Application
Forensic Application

Buy this Report now at

Contact us –

Contact Person : Sameer Joshi

Phone : +1-646-491-9876

Email Id :


The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Media, Healthcare and Telecommunication industries.

Comments (0)

Add comment


By submitting the comment you agree that your personal data will be processed according to Mynewsdesk's Privacy Policy.